NOBORI 2: a prospective, multi-centre, observational study of the Nobori [biolimus-A9] drug eluting stent system.

Trial Profile

NOBORI 2: a prospective, multi-centre, observational study of the Nobori [biolimus-A9] drug eluting stent system.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms NOBORI 2
  • Sponsors Terumo
  • Most Recent Events

    • 04 Sep 2013 Results from seven major Italian cath labs presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
    • 10 Apr 2009 Status is active, no longer recruiting according to a Terumo media release.
    • 28 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top